CClinicalTrials.gg
Status unknownNCT03305276OIVITAUpdated Oct 9, 2017

Observatory on Impact of Life Styles on Health Outcomes

An observational study in Outcome, sponsored by Guido Iaccarino. Status unknown at 1 site in Italy. Open to participants aged 14 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-09.

Sponsored by Guido Iaccarino · Observational

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Ecologic or community
Time perspective
Retrospective
Enrollment
1,500
Ages
14 Years to 100 Years
Sex
All
01

Study summary

The present is an observational study conducted on the general population in villages of Southern Italy every year during the world hypertension day. So far, A total of 412 persons (193 males and 219 female, 14-85 years) were recruited during the XI and XII World Hypertension Day (2015 and 2016). The study was approved by the relevant institutional Ethical Committee of Salerno University.

Read the detailed description

In occasion of the World Hypertension Day in may , boots are organized in the major squares of the southern italy villages, and volunteers of the Medical School of Salerno collect through means of questionnaires, anamnestic data and dietary habits, and measure blood pressure after 5 minutes in the sitting position, 3 times with an interval of 2 minutes using validated, ESH approved electronic oscillometer (A100, Microlife, Italy), according to the ESC/ESH guidelines. Other questions regard previous cardiovascular conditions or events (coronary heart disease) and cardiovascular accidents (TIA and stroke). Eventual drug treatment and Vitamin D supplementation is also annotated. A venous blood sample is drawn from the antecubital vein and blood is stored for biochemical analysis at the University Hospital Centralized Service. Data are digitally stored for analysis.

Anamnestic and biochemical data regarding age, sex-specific cholesterol, HDL cholesterol, systolic BP and cigarette smoking pre-existing conditions and way of life are used for the calculation of cardiovascular risk according to the Framingham Cardiovascular Risk Score. Familiarity for cardiovascular disease is defined as cardiovascular events in parents and siblings less than 50 years old.

The validated questionnaire alternate Mediterranean Diet Score (aMed), is administered to assess adherence to the Mediterranean Diet . Laboratory assessment of blood samples. A venous blood sample was collected in two tubes of 5.0 ml and centrifuged in the day. The time of the last meal was recorded during the data collection. Blood glucose, insulin, blood urea nitrogen (BUN), creatinine, calcium, phosphorus, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, 25(OH)D, PTH, Vitamin B-12 and folic acid are assessed. Glomerular filtration rate (GFRs) is estimated using the equation of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) .

02

Conditions studied

  • Outcome

Keywords

  • diet;
  • exercise;
  • hypertension;
  • vitamin d
03

Who can participate

Ages eligible
14 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Volunteers from Southern Italy will be recruited in occasion of health promoting events in villages.

Inclusion criteria

  • General population

Exclusion criteria

Exclusion Criteria:

  • Subjects who do not sign informed consent and do not give authorization will be excluded from the study
  • Subjects fed through parenteral feeding
04

Study design

Observational model
Ecologic or community
Time perspective
Retrospective
Enrollment
1,500 participants (estimated)
Patient registry
No

Groups and cohorts

  • general population

    the study is open to all population, (14-90 years, male/female) to verify the impact of lifestyles (mediterranean style) on intermediate and hard endpoint.

05

What researchers measure

Primary outcomes

  1. cardiovascular events

    Presence of events in the anamnesis of subjects enrolled

    Time frame: 10 year

Secondary outcomes

  1. cardiovascular risk

    Framingham Risk Score

    Time frame: 10 years

Other outcomes

  1. vitamin D profile

    vitamin d serum levels will be assessed and compared to the life style

    Time frame: 10 years

  2. vitamin B12 profile

    vitamin b12 serum levels will be assessed and compared to the life style

    Time frame: 10 years

  3. Folic Acid profile

    folic acid serum levels will be assessed and compared to the life style

    Time frame: 10 years

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03305276
Lead sponsor
Guido Iaccarino
Responsible party
Guido Iaccarino (Associate Professor of Internal Medicine, Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona) — Sponsor-investigator
First posted
Oct 9, 2017
Start date
May 16, 2014
Primary completion
Jul 16, 2020 (estimated)
Completion
May 16, 2024 (estimated)
Last update
Oct 9, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion